Home
>
National Drug Code (NDC)
>
Olanzapine
Olanzapine - 66993-053-30 - (Olanzapine)
Drug Information of Olanzapine
| Product NDC: | 66993-053 |
| Proprietary Name: | Olanzapine |
| Non Proprietary Name: | Olanzapine |
| Active Ingredient(s): | 5 mg/1 & nbsp; Olanzapine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Olanzapine
| Product NDC: | 66993-053 |
| Labeler Name: | Prasco Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021086 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20111023 |
Package Information of Olanzapine
| Package NDC: | 66993-053-30 |
| Package Description: | 30 DOSE PACK in 1 CARTON (66993-053-30) > 1 BLISTER PACK in 1 DOSE PACK (66993-053-81) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Information of Olanzapine
| NDC Code | 66993-053-30 |
| Proprietary Name | Olanzapine |
| Package Description | 30 DOSE PACK in 1 CARTON (66993-053-30) > 1 BLISTER PACK in 1 DOSE PACK (66993-053-81) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Product NDC | 66993-053 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Olanzapine |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20111023 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Prasco Laboratories |
| Substance Name | OLANZAPINE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
